Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?
Sara Baldelli, Mario Corbellino, Emilio Clementi, Dario Cattaneo, Cristina Gervasoni
Topics & Concepts
LopinavirLopinavir/ritonavirCoronavirus disease 2019 (COVID-19)RitonavirVirology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicinePandemicInternal medicineHuman immunodeficiency virus (HIV)Viral loadAntiretroviral therapyInfectious disease (medical specialty)OutbreakDiseaseCOVID-19 Clinical Research StudiesInfectious Encephalopathies and EncephalitisAntibiotics Pharmacokinetics and Efficacy